Clinical Efficacy of Transdermal Fentanyl Pathches for Post-Operative Pain Mangement in Dogs

Loading...
Thumbnail Image
Date
2018
Journal Title
Journal ISSN
Volume Title
Publisher
MAFSU, Nagpur
Abstract
In todays scenario dogs undergo a vast variety of surgeries following which they experience considerable pain. Pain management is central to veterinary practice. Routinely used post-operative pain management regimens may prove to be either inadequate or stressful for the animals due to frequent administration of injectables. Thus, a sustained release analgesic using a transdermal delivery system was studied. The present study was designed to evaluate the clinical efficacy of transdermal fentanyl patches for managing post-operative pain following ovariohysterectomy in 12 dogs. Group 1 (n=6) received a single transdermal fentanyl patch applied (on the dorsal cervical region) 18h prior to surgery while Group 2 (n=6) receivedintramuscular injections of buprenorphine prior to surgery and repeated at 12h intervals for 3 days. Minimal alterations in clinico-physiological parameters were observed. Mild reductions in rectal temperature (p<0.05) and minor increases in heart (p<0.05) and respiratory rates (p<0.01) were noted in dogs treated with transdermal fentanyl. All dogs exhibited leukocytosis (p<0.05) and monocytosis from the beginning of the study. Mild increase in PCV (p<0.05) was noted prior to surgery. Neutophilia without shift to left (p<0.01) and lymphopenia (p<0.05) were observed 24h after surgery. Serum creatinine values varied between intervals (p<0.05) in both groups while mean values of BUN were significantly lower (p<0.01) in dogs receiving transdermal fentanyl. ALT values differed non-significantly in both groups whereas AST increased significantly (p<0.01) in the transdermal fentanyl group. No adverse effects were observed in any of the dogs throughout the study. Short Form of the Glasgow Composite Measure Pain Scale was used to quantify the amount of pain experienced by each dog. Assessment of spontaneous and evoked behaviours, interactions with these dogs and clinical observations recorded at different time points of the study showed no stiffness in gait or reluctance to move in any of the dogs. The dogs remained behaviorally comfortable, quiet and ignored their surgical incision sites. Maximum variation in pain exhibited by the dogs was observed on application of gentle pressure 2 inches around the surgical wound. Snapping, growling, guarding the surgical site, flinching, looking around and no reaction to pressure applied were observed in the operated dogs. The maximum pain score in the transdermal fentanyl patch group was 3 out of 24 whereas in the buprenorphine group it was 4 out of 24. Extreme pain reactions like groaning, screaming, licking or chewing of the wound, hunched or tense abdomen and non-responsiveness to stimulation were not observed in any case indicating adequate analgesia. Kruskal-Wallis H test was applied to analyze pain scores between both groups. Mean ranks did not differ significantly for the groups, however, slight fluctuations in pain were observed in the transdermal fentanyl group. Pain scores of dogs in both groups reduced as the study progressed. Rescue analgesia was not required to be administered at any time point in either of the groups. The study demonstrates that the use of transdermal fentanyl patches applied 18h prior to ovariohysterectomy provides postoperative analgesia for 3 days which is non-inferior to repeated injections of buprenorphine. It can be concluded that, transdermal fentanyl patches paired with NSAID will provide reliable multimodal analgesia when used for abdominal surgery in dogs, which is expected to produce substantial postoperative pain if left untreated.
Description
Keywords
null
Citation
Collections